![Adrian Curran](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Adrian Curran is associated with Adan Medical Innovation SL as a Medical Advisor.
Mr. Curran is the founder of Adan Medical Innovation SL, which was founded in 2013.
Actieve functies van Adrian Curran
Bedrijven | Functie | Begin |
---|---|---|
Adan Medical Innovation SL
![]() Adan Medical Innovation SL Medical SpecialtiesHealth Technology Adan Medical Innovation SL is a Spanish company that aims to increase education and awareness about anaphylaxis and its treatment to prevent fatal outcomes. Adan Medical Innovation is based in Bilbao, ES. The company has developed Allergobox, a smart medical device connected to a telecontrol platform that helps manage autoinjectors of adrenaline to treat anaphylaxis in public spaces. The concept of Alergoprotección was created to protect public spaces against fatal outcomes of severe allergic reactions and to raise awareness about anaphylaxis. The company's mission is to improve the quality of life of patients who suffer from severe allergic reactions. The company was founded in 2013 by Adrian Curran, Anna Sala. Xavier Guillem has been the CEO of the company since 2015. | Oprichter | 01-07-2013 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Adan Medical Innovation SL
![]() Adan Medical Innovation SL Medical SpecialtiesHealth Technology Adan Medical Innovation SL is a Spanish company that aims to increase education and awareness about anaphylaxis and its treatment to prevent fatal outcomes. Adan Medical Innovation is based in Bilbao, ES. The company has developed Allergobox, a smart medical device connected to a telecontrol platform that helps manage autoinjectors of adrenaline to treat anaphylaxis in public spaces. The concept of Alergoprotección was created to protect public spaces against fatal outcomes of severe allergic reactions and to raise awareness about anaphylaxis. The company's mission is to improve the quality of life of patients who suffer from severe allergic reactions. The company was founded in 2013 by Adrian Curran, Anna Sala. Xavier Guillem has been the CEO of the company since 2015. | Health Technology |